Rosetta Inpharmatics
Rosetta Inpharmatics, part of Merck & Co., Inc., has been committed to innovative research in biopharmaceuticals for over 130 years, focusing on developing important medicines and vaccines across various therapeutic areas, including oncology, immunology, and infectious diseases. The company aspires to be a leader in research-intensive biopharmaceuticals, operating responsibly to ensure a safe and healthy future for communities globally.
Through its clinical trials and collaborations, Rosetta Inpharmatics aims to address significant scientific challenges and improve patient care by advancing new treatments. The company's commitment to sustainability and social responsibility is evident in its initiatives, such as the Merck for Mothers program, which seeks to create a world where no woman dies giving life.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.